Ausgabe 9/2018
Inhalt (7 Artikel)
Adis Drug Q&A
Hialid®/Hyalein® (sodium hyaluronate) ophthalmic solution in dry eye syndrome: a profile of its use
Kate McKeage, Katherine A. Lyseng-Williamson
Adis Drug Q&A
Amphetamine extended-release oral suspension (Adzenys ER™) and orally disintegrating tablets (Adzenys XR-ODT®) in attention-deficit hyperactivity disorder: a profile of their use
Katherine A. Lyseng-Williamson
Drug Reactions and Interactions
Preventing and managing dimethyl fumarate-related adverse effects in patients with multiple sclerosis may improve adherence
Adis Medical Writers
Review Article
Phenobarbital monotherapy for alcohol withdrawal syndrome in the non-intensive care unit setting: a review
Stephanie V. Phan
Original Research Article
Associations between Drug Burden Index, medication appropriateness and patient-reported outcomes in the community pharmacy setting in Malaysia
Syed Shahzad Hasan, Annita Shi Chin Liew, David Weng Kwai Chong, Kaeshaelya Thiruchelvam, Zaheer-Ud-Din Babar
Original Research Article
Management and outcome of Stevens–Johnson syndrome and toxic epidermal necrolysis in patients admitted to Kenyatta National Hospital
K. K. Irungu, D. G. Nyamu, S. A. Opanga